USP39 is frequently overexpressed in a range of cancers, including head and neck squamous cell carcinoma (HNSCC), oral squamous cell carcinoma (OSCC), nasopharyngeal carcinoma (NPC), medullary thyroid carcinoma (MTC), melanoma, and leukemia. This evidence concerns the gene USP39 and medullary thyroid gland carcinoma.